Pubblicazioni

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases

2022 - CURRENT NEUROPHARMACOLOGY
Maftei, Daniela; Schirinzi, Tommaso; Mercuri, Nicola B; Lattanzi, Roberta; Severini, Cinzia

Monoamine-Oxidase type B- Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action

2022 - CURRENT NEUROPHARMACOLOGY
Rinaldi, Domiziana; Alborghetti, Marika; Bianchini, Edoardo; Sforza, Michela; Galli, Silvia; Pontieri, Francesco E

Different generations of type-b monoamine oxidase inhibitors in parkinson’s disease: From bench to bedside

2019 - CURRENT NEUROPHARMACOLOGY
Alborghetti, M.; Nicoletti, F.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma